To determine if the RNR M2 subunit switching we observed in vitro occurred in vivo, we collected HB214 tumors two days and 34 days post irinotecan treatment and performed RRM2 and RRM2B RNAscope staining on tumor sections. This evidence concerns the gene RRM2 and neoplasm.